Squamous cell carcinoma arising from mature cystic teratoma of the ovary: A clinicopathologic analysis

Obstetrics and Gynecology

Volumn 89, Issue 6, 1997, Pages 1017-1022

  Kikkawa, Fumitaka ^a   Ishikawa, Hisatake ^b   Tamakoshi, Koji ^b   Nawa, Akihiro ^b   Suganuma, Nobuhiko ^b   Tomoda, Yutaka ^b  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ABDOMINAL HYSTERECTOMY; ADULT; AGED; ARTICLE; CANCER GRADING; CANCER INFILTRATION; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; FEMALE; HUMAN; HUMAN TISSUE; OMENTUM; OVARY CARCINOMA; OVARY TERATOMA; PRIORITY JOURNAL; PROGNOSIS; SALPINGOOOPHORECTOMY; SQUAMOUS CELL CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; FEMALE; HUMANS; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; NEOPLASMS, MULTIPLE PRIMARY; OVARIAN NEOPLASMS; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE; TERATOMA;

EID: 0030953138     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0029-7844(97)00117-8     Document Type: Article

References (14)

1. Peterson WF. Malignant degradation of benign cystic teratomas of the ovary - A collective review of the literature. Obstet Gynecol Surv 1957;12:793-830.
2. Hirakawa T, Tsuneyoshi M, Enjoji M. Squamous cell carcinoma arising in mature cystic teratoma of the ovary. Am J Surg Pathol 1989;13:397-405.
3. Broders AC. Squamous-cell epithelioma of the skin. Ann Surg 1921;2:141-60.
4. Kikkawa F, Ishikawa H, Tamakoshi K, Suganuma N, Kawai M, Tomoda Y, et al. Prognostic evaluation of lymphadenectomy for epithelial ovarian cancer. J Surg Oncol 1995;60:227-31.
5. Scambia GP, Panici B, Foti E, Amoroso M, Salerno G, Ferrandina G, et al. Squamous cell carcinoma antigen: Prognostic significance and role in the monitoring of neoadjuvant chemotherapy response in cervical cancer. J Clin Oncol 1994;12:2309-16.
6. Singh P, Yordan EL, Wilbanks GD, Miller AW, Wee A. Malignancy associated with benign cystic teratomas (dermoid cysts) of the ovary. Singapore Med J 1988;29:30-4.
7. Kikkawa F, Kawai M, Mizuno K, Ishikawa H, Kojima M, Maeda O, et al. Recurrence of epithelial ovarian carcinoma after clinical remission. Gynecol Obstet Invest 1994;32:65-9.
8. Kawai M, Kikkawa F, Hattori S, Ohta M, Arii Y, Tomoda Y. Long-term follow-up of patients with epithelial carcinoma of the ovary. Int J Gynecol Obstet 1994;44:259-66.
9. Kuehnle H, Meerpohl HG, Eiermann W, Achterrath W. Neoadjuvant therapy for cervical cancer. Semin Oncol 1992;19:94-8.
10. Kikkawa F, Kawai M, Mizuno K, Ishikawa H, Kojima M, Maeda O, et al. Recurrence of epithelial ovarian carcinoma after clinical remission. Gynecol Obstet Invest 1994;32:65-9.
11. Piver MS, Lele SB, Marchetti DL, Baker TR, Tsukada Y, Emrich LJ. The impact of aggressive debulking surgery and cisplatin-based chemotherapy on progression-free survival in stage III and IV ovarian carcinoma. J Clin Oncol 1988;6:983-9.
12. Stamp GWH. Malignancy arising in cystic ovarian teratomas. A report of 24 cases. Br J Obstet Gynaecol 1983;90:671-5.
13. Curling OM, Potsides PN, Hudson CN. Malignant change in benign cystic teratoma of the ovary. Br J Obstet Gynaecol 1979;86: 399-402.
14. Suzuki M, Kobayashi H, Sekiguchi I, Terao T, Sato I. Clinical evaluation of squamous cell carcinoma antigen in squamous cell carcinoma arising in mature cystic teratoma of the ovary. Oncology 1995;52:287-90.